ClinConnect ClinConnect Logo
Search / Trial NCT05677581

Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum

Launched by BEIJING FRIENDSHIP HOSPITAL · Dec 28, 2022

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how iodine nutrition affects thyroid function in women during pregnancy and up to six weeks after giving birth. Iodine is an essential nutrient that helps the thyroid gland produce hormones important for metabolism and overall health. The researchers want to understand how iodine levels change at different stages of pregnancy and after childbirth, and how these changes might affect thyroid function. By gathering this information, they hope to create better guidelines for iodine intake for pregnant women and new mothers.

To participate in the study, women must be healthy and aged between 20 and 40 years. They should be first-time mothers with no serious health issues like chronic diseases or a history of thyroid problems. Participants will provide urine samples to measure iodine levels and undergo tests to check their thyroid function. This study is currently recruiting participants, and it aims to improve the understanding of maternal iodine nutrition and its impact on health during pregnancy and postpartum.

Gender

FEMALE

Eligibility criteria

  • 8-12 weeks healthy maternal:
  • Inclusion Criteria:
  • primigravida
  • no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases before pregnancy
  • no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases before pregnancy
  • no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases before pregnancy
  • Exclusion Criteria:
  • multiple pregnancies and multigravida
  • a history of type I or type II diabetes before pregnancy
  • a clear history of thyroid diseases before pregnancy
  • taking drugs that affect thyroid function and/or blood sugar before or during early pregnancy
  • Healthy women of childbearing age:
  • Inclusion Criteria:
  • 20-40 years old
  • no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases
  • no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases
  • no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases
  • Exclusion Criteria:
  • a history of type I or type II diabetes
  • a clear history of thyroid diseases
  • taking drugs that affect thyroid function and/or blood sugar

About Beijing Friendship Hospital

Beijing Friendship Hospital, affiliated with Capital Medical University, is a leading comprehensive medical institution located in Beijing, China. Renowned for its advanced clinical services and cutting-edge research, the hospital plays a pivotal role in promoting healthcare innovation and improving patient outcomes. As a prominent clinical trial sponsor, Beijing Friendship Hospital is committed to conducting high-quality, ethical research that adheres to international standards. The hospital's multidisciplinary teams leverage their expertise across various medical fields to facilitate the development of new therapies and interventions, ultimately contributing to the advancement of medical science and public health.

Locations

Beijing, , China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials